Most practices choose a financing partner the way a patient chooses a mattress: lie on it for ten minutes, check the price tag, sign. They compare promotional rates, maybe the merchant fee, and pick the lender with the shiniest 0% badge. Then they wonder why half their treatment plans never close. The variable that actually moves revenue is not the rate. It is the share of your applicants who get approved, and almost no practice tracks it.
Patient financing options only convert revenue when patients actually get approved for them. A 0% APR offer that approves 35% of applicants is worse than a 15.9% plan that approves 70%. The math is not close, and most front desks have never been asked to run it.
Why Approval Rate Beats Interest Rate Every Time
A declined applicant does not call the next lender. They do not ask about a payment plan. They thank the coordinator, say they'll "think about it," and never book the procedure. That patient is not lost to a competitor. They are lost to inertia, and your practice's conversion funnel ends there whether anyone logs it or not.
Run the numbers on a typical elective case worth $6,000. If your primary lender approves 40% of applicants and you see 100 financing inquiries a month, you close 40 cases. Swap to a lender that approves 65% of comparable applicants at a slightly higher rate, and you close 65 cases from the same lead volume. No new marketing spend, no new staff. The only thing that changed is who said yes.
The Metric Most Practices Never Calculate
Ask your office manager right now what percentage of financing applicants get approved at your practice. Most cannot answer. They know the lender's name and maybe the merchant discount rate, but nobody tracks approvals against applications because the lender's portal does not make it easy and nobody assigned the job.
Start pulling this number monthly. Applications submitted, approvals granted, approval rate as a percentage, and a breakdown by credit tier if your lender provides one. Without this number you are optimizing blind, and every assumption you make about "patients can't afford it" is actually a lender problem wearing a patient's face.
Second-Look Lenders Catch Revenue You're Already Losing
Single-lender financing programs leave real money on the table because every lender underwrites differently. A patient declined by your primary provider for a thin credit file may sail through a second lender that weighs bank account activity instead of just a FICO score. This is not a marginal edge case. It is a structural gap in how consumer lending works.
How a Waterfall Actually Works
A financing waterfall routes a declined applicant automatically to a second, and sometimes third, lender with different underwriting criteria. The patient fills out one form. If lender A declines, the system passes the application to lender B without the patient re-entering information or feeling rejected in between.
| Single-Lender Setup | Waterfall Setup |
|---|---|
| One approval decision, one outcome | Two to three underwriting passes on one application |
| Declined patients see a hard "no" | Declined patients move silently to next lender |
| Approval rate capped by one lender's risk model | Approval rate reflects the best-fit lender per applicant |
| Typical approval range: 35%-55% | Typical approval range: 55%-75% |
Vendors like Cherry, Sunbit, PatientFi, and Proceed Finance all offer some form of multi-lender routing, though the exact partners and underwriting logic differ by vendor and change over time. Ask any financing vendor directly how many lenders sit behind their application and what the blended approval rate looks like across your specialty, not their platform-wide average. A dental practice and a plastic surgery practice see different applicant profiles, and a vendor's headline approval number is usually an average across both.
Credit Tiers Are Not Optional to Understand
Credit tier
A lender's internal risk classification of an applicant, typically based on credit score bands, that determines approval likelihood and the rate or term offered.
Prime applicants, generally those with strong credit histories, get approved almost everywhere and the lender choice barely matters for them. The fight is over near-prime and subprime applicants, who make up a larger share of elective-procedure inquiries than most owners assume. If your only lender skews toward prime-only underwriting, you are quietly filtering out a big chunk of patients who could have been treated with the right second-look partner in place.
Presenting Financing Without Making It the Headline
Financing works best when it is a quiet enabler, not the centerpiece of the consult. Lead with the clinical plan and the outcome goals discussed, then introduce payment structure as one of several ways to move forward. Patients who feel sold a loan trust the practice less than patients who feel guided toward a plan that fits their clinical needs.
Script Discipline at the Front Desk
Train coordinators to present financing as a logistics detail, not a pitch. The difference in phrasing changes how patients perceive the entire conversation.
Banned: "This is going to cost a lot, but don't worry, we can get you financed so it won't feel like it."
Compliant: "Here's the full investment for your treatment plan. Most patients use one of three payment paths, and I can walk you through what fits your situation."
The compliant version treats the patient as a decision-maker, not a credit risk to be managed around. It also avoids any implication that the practice is minimizing a legitimate cost, which creates distrust the moment the first statement arrives.
Timing Matters as Much as Wording
Bring up financing after the clinical plan is set and the patient has emotionally committed to treatment, not during the initial pricing conversation. Patients who hear "payment options" before they hear "here's your plan" tend to anchor on cost rather than outcome, and that anchor is hard to undo later in the same conversation.
Case acceptance
The share of presented treatment plans a patient agrees to, measured in dollars rather than in cases.
Case acceptance in dollars, not just case counts, is the number that tells you whether your financing stack is actually working. A practice that accepts 80% of its cases by count but only 55% by dollar value is losing its highest-ticket patients to sticker shock, financing or no financing. Track both numbers separately every month.
Auditing Your Current Financing Stack
Most practices have never formally audited their lender relationship past the initial sales pitch. Here is the minimum diagnostic every administrator should run quarterly.
- Pull the raw approval rate. Applications versus approvals, not the lender's marketing claim.
- Segment by credit tier if your vendor provides it. A blended number hides where you're actually losing patients.
- Ask what happens to declines. If the answer is "nothing," you need a second-look lender in the stack.
- Compare case acceptance in dollars, not cases. A high case count with low dollar acceptance means you're closing cheap cases and losing expensive ones.
- Review the patient-facing script. If coordinators lead with financing before the clinical plan, that is a training fix, not a lender fix.
None of this requires new marketing spend. It requires someone in the practice owning the number and reviewing it as seriously as new patient volume.
What to Ask a Financing Vendor Before Signing
Every financing vendor pitch sounds the same: fast approvals, low merchant fees, happy patients. Push past the pitch with specific questions.
Questions That Separate Real Partners from Rate Shopping
Ask for the blended approval rate specific to your specialty, not the platform average across every vertical they serve. Ask whether declined applicants route to a second lender automatically or whether that is a separate integration you have to build. Ask what percentage of approved patients actually fund the loan and complete the procedure, since approval and funding are not the same event and some vendors only report the more flattering number.
Get these answers in writing before signing a contract, and revisit them annually. Lenders change underwriting criteria in response to default rates and macroeconomic conditions, and a vendor that approved 65% of your applicants two years ago may be approving 45% today without ever notifying you.
Key takeaways
- Approval rate determines how many financing applicants actually become paying patients, and it matters more than the promotional interest rate on the offer.
- A declined patient typically does not seek a second financing option on their own; they disappear from the funnel entirely.
- Second-look lenders and financing waterfalls route declined applicants to a different underwriting model instead of ending the conversation at the first no.
- Case acceptance should be measured in dollars as well as case count, because a practice can accept most cases while still losing its highest-value patients.
- Financing should be presented after the clinical plan is set, framed as a logistics detail rather than the centerpiece of the consult.
- Ask every financing vendor for your specialty-specific approval rate in writing, not a platform-wide average across unrelated verticals.
Frequently asked questions
- What is a good patient financing approval rate?
- A strong blended approval rate for elective medical and dental financing typically falls between 60% and 75% when a second-look lender is in place. Single-lender programs without a waterfall often approve closer to 35% to 55%, which means roughly half of interested patients are quietly disappearing from the funnel.
- How do second-look lenders work in patient financing?
- A second-look lender automatically reviews applicants declined by the primary financing partner, often using different underwriting criteria such as bank account activity instead of credit score alone. The patient submits one application, and if the first lender declines, the system routes the application to the next lender without the patient having to reapply or feel rejected.
- Should financing be mentioned before or after the treatment plan?
- Bring up financing after the clinical plan is presented and the patient has engaged with the recommended treatment, not during the initial pricing discussion. Patients who hear payment options before the plan itself tend to anchor on cost rather than outcome, which lowers case acceptance even when financing is available.
- What's the difference between approval rate and case acceptance?
- Approval rate measures what percentage of financing applicants get approved by the lender, while case acceptance measures what percentage of presented treatment plans patients agree to move forward with. Case acceptance should be tracked in dollars as well as case count, since a practice can have a high case acceptance rate while still losing its most expensive cases.
- How often should a practice audit its financing vendor?
- Review your financing vendor's approval rate and terms at least annually, since lenders adjust underwriting criteria in response to default rates and economic conditions. A vendor approving 65% of applicants two years ago may be approving significantly fewer today without ever notifying the practice.
See where your own growth leaks.
The free Practice Growth Audit traces your demand, your follow-through and your measurement, and hands you the gaps in writing. Built by hand, yours to keep.
